Patents by Inventor Wade C. Anderson

Wade C. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190000969
    Abstract: Provided are novel anti-UPK1B antibodies and antibody drug conjugates, and methods of using such anti-UPK1B antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 3, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: KRISTEN MCKNIGHT, SARAH FONG, SAMUEL A. WILLIAMS, ZHAO HUANG, EARL KIM, ROBERT A. STULL, DAVID COELHO, WADE C. ANDERSON, MARIANNE SANTAGUIDA
  • Publication number: 20180243435
    Abstract: Provided are novel anti-DLL3 antibodies and antibody drug conjugates, and methods of using such anti-DLL3 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 30, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SCOTT J. DYLLA, BRIAN SLINGERLAND, TAE HAN, JOHN PEATTIE, HOLGER KARSUNKY, WADE C. ANDERSON
  • Patent number: 10017565
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: July 10, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • Patent number: 9945842
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: April 17, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Scott J. Dylla, Marianne Santaguida, Wade C. Anderson
  • Publication number: 20180067120
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 8, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SCOTT J. DYLLA, MARIANNE SANTAGUIDA, WADE C. ANDERSON, BOB Y. LIU, SAMUEL A. WILLIAMS
  • Patent number: 9778264
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: October 3, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Scott J. Dylla, Marianne Santaguida, Wade C. Anderson, Bob Y. Liu, Samuel A. Williams
  • Publication number: 20170081419
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: August 29, 2016
    Publication date: March 23, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • Patent number: 9458231
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: October 4, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • Publication number: 20150030636
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Application
    Filed: August 7, 2014
    Publication date: January 29, 2015
    Applicant: STEM CENTRX, INC.
    Inventors: SCOTT J. DYLLA, MARIANNE SANTAGUIDA, WADE C. ANDERSON, BOB Y. LIU, SAMUEL A. WILLIAMS
  • Publication number: 20130302355
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyper-proliferative disorders are provided.
    Type: Application
    Filed: September 2, 2011
    Publication date: November 14, 2013
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • Publication number: 20130260385
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Application
    Filed: September 2, 2011
    Publication date: October 3, 2013
    Inventors: Scott J. Dylla, Marianne Santaguida, Wade C. Anderson
  • Publication number: 20130061340
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Application
    Filed: March 7, 2012
    Publication date: March 7, 2013
    Inventors: Scott J. Dylla, Marianne Santaguida, Wade C. Anderson, Bob Y. Liu, Samuel A. Williams
  • Publication number: 20130061342
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Application
    Filed: February 8, 2012
    Publication date: March 7, 2013
    Inventors: Scott J. Dylla, Marianne Santaguida, Wade C. Anderson, Bob Y. Liu, Samuel A. Williams